Abstract:Fucosylation is one of the most prevalent modifications on N- and O-glycans of glycoproteins, and it plays an important role in various cellular processes and diseases. Small molecule inhibitors of fucosylation have shown promise as therapeutic agents for sickle cell disease, arthritis, and cancer. We describe here the design and synthesis of a panel of fluorinated l-fucose analogs bearing fluorine atoms at the C2 and/or C6 positions of l-fucose as metabolic fucosylation inhibitors. Preliminary study of their effects on cell proliferation revealed that the 6,6-difluoro-l-fucose (3) and 6,6,6-trifluoro-l-fucose (6) showed significant inhibitory activity against proliferation of human colon cancer cells and human umbilical vein endothelial cells. In contrast, the previously reported 2-deoxy-2-fluoro-l-fucose (1) had no apparent effects on proliferations of all the cell lines tested. To understand the mechanism of cell proliferation inhibition by the fluorinated l-fucose analogs, we performed chemoenzymatic synthesis of the corresponding GDP-fluorinated l-fucose analogs and tested their inhibitory activities against the mammalian α1,6-fucosyltransferase (FUT8). Interestingly, the corresponding GDP derivatives of 6,6-difluoro-l-fucose (3) and 6,6,6-trifluoro-l-fucose (6), which are the stronger proliferation inhibitors, showed much weaker inhibitory activity against FUT8 than that of the 2-deoxy-2-fluoro-l-fucose (1). These results suggest that FUT8 is not the major target of the 6-fluorinated fucose analogs (3 and 6). Instead, other factors, such as the key enzymes involved in the de novo GDP-fucose biosynthetic pathway and/or other fucosyltransferases involved in the biosynthesis of tumor-associated glyco-epitopes are most likely the targets of the fluorinated l-fucose analogs to achieve cell proliferation inhibition. To our knowledge, this is the first comparative study of various fluorinated l-fucose analogs for suppressing the proliferation of human cancer and primary endothelial cells required for angiogenesis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00228?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00228</a>.Detailed experimental procedures; synthesis of the fluorinated l-fucose analogs used in the study; chemoenzymatic synthesis of the GDP-fluorinated-l-fucose derivatives; copies of 1H, 13C, 19F and 31P NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00228/suppl_file/cb0c00228_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Fucosylated Oligosaccharides in Hepatoma Cell Migration Inhibition by N(4-hydrophenyl) Retinamide

Fucosylated Ogligosaccharides in the Migration of Hepatoma Cells

Fucosylated Glycan Inhibition of Human Hepatocellular Carcinoma Cell Migration Through Binding to Chemokine Receptors

[Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide].

Inhibitory Effects of N-（4-hydrophenyl） Retinamide on Liver Cancer and Malignant Melanoma Cells

Fucoidan Induces Apoptosis of Hepg2 Cells by Down-Regulating P-Stat3

Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells: Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells

Antimetastatic Effect of Fucoidan-Sargassum Against Liver Cancer Cell Invadopodia Formation Via Targeting Integrin Αvβ3 and Mediating Αvβ3/src/e2f1 Signaling.

F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration

Synthetic Fluorinated l -Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells

Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth

A comparison of the effect of fucoidan from alga Fucus vesiculosus and its fractions obtained by anion-exchange chromatography on HeLa G-63, Hep G2, and Chang liver cells

Inhibition of fucosylation by 2-fluorofucose attenuated acetaminophen-induced liver injury via its anti-inflammation and anti-oxidative stress effects

Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways

Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

The Chemical Profiling and Anticancer Potential of Functional Polysaccharides from Flos Sophorae Immaturus

Regulation of α-1,6Fucosyltransferase by Estrogen and Progesterone in Human Hepatoma SMMC-7721 Cells

In vitro and in vivo immunomodulatory effects of fucoidan compound agents

Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells

Anti-Metastasis Effect of Fucoidan from Undaria pinnatifida Sporophylls in Mouse Hepatocarcinoma Hca-F Cells